
Greenlife Pharmaceuticals Limited, a major player in Nigeria’s pharmaceutical industry, has unveiled the Pharmacy Access and Commercial Trade (PACT) 2026, an initiative aimed at strengthening relationships with its trade partners and promoting sustainable growth across the pharmaceutical value chain.
The inaugural PACT forum, held at the Radisson Blu Hotel, GRA, Ikeja, Lagos, brought together key wholesale and trade partners to recognise businesses that partnered with Greenlife during the 2025–2026 financial year and to discuss institutionalisation, strategic partnerships and long-term business growth.
Speaking at the event, the Executive Director of Greenlife Pharmaceuticals Limited, Pharm. Peter Chukwudalu Nwosu, said the initiative was designed to move the company’s relationship with its partners beyond routine commercial transactions.
According to him, Greenlife’s next phase would focus on listening better to its customers, responding faster, making business easier and understanding the challenges of its partners. He said stronger relationships remained critical to the company’s growth, particularly in a challenging business environment characterised by rising operating costs.
Nwosu also disclosed that Greenlife was working towards local manufacturing, noting that rising costs of active pharmaceutical ingredients and excipients had continued to put pressure on the pharmaceutical industry. He said government measures aimed at reducing the cost burden on manufacturers could support the transition.
The General Manager, Sales and Marketing, Pharm. Derick Osondu, said PACT represented part of Greenlife’s effort to build a closer and more responsive relationship with its partners. He urged participants to provide honest feedback through the company’s feedback channels to enable Greenlife to improve its services.

He said the company’s growth had been shaped not only by its internal efforts but also by the trust and commitment of the businesses that have worked with it over the years. Osondu noted that the forum therefore provided an opportunity for Greenlife to appreciate its partners while creating a platform for deeper engagement and shared growth.
Speaking on “Sustainable Pharma Access and Commercial Trade through Institutionalization,” the company’s Corporate Performance and Strategy representative, Mr Jones Ekwealor, challenged trade partners to build businesses that could survive beyond their founders.
He identified governance, finance, systems and processes, people, and strategy as five critical pillars for institutionalising businesses. He also stressed the need for proper financial records, effective inventory and credit controls, competent management, succession planning and reliable business data.
Ekwealor further warned businesses to prepare adequately for the evolving tax environment, stressing that poor reconciliation of sales, inventory, customer records, bank transactions and tax obligations could expose businesses to avoidable risks.
The Business Development Manager, Pharm. Henry Okolo, explained that PACT was structured around the principle of exponential growth and long-term partnership. He said the initiative would move beyond conventional discounts by creating additional value for partners through structured commercial opportunities.
He described the initiative as a commitment framework intended to encourage sustained business growth rather than a one-off commercial incentive, urging partners to embrace opportunities that would strengthen their businesses and deepen their relationship with Greenlife.
A former National Chairman of the National Association of Industrial Pharmacists (NAIP) and Chief Operating Officer of Alpha Pharmacy and Stores Ltd., Pharm. Ignatius Anuku, commended Greenlife for the initiative, describing it as evidence of the company’s long-term strategic thinking.
Anuku also called for greater investment in local pharmaceutical manufacturing, saying Nigeria could not depend indefinitely on imported medicines to meet the healthcare needs of its growing population. He urged pharmaceutical companies and trade partners to build relationships based on trust, communication and mutual benefit.
The event climaxed with the presentation of awards to outstanding Greenlife partners. SS & Duke Pharmaceutical Limited was the first recipient, while Medplus Pharmacy received the Lonart Legacy Award. Grace Johnson Pharmaceutical Limited received the P-Alaxin Legacy Award, DrugStoc EHub Limited was honoured with Portfolio Excellence Award, while New Heights Wholesales Limited won the Funbact A Legacy Award.
According to Pharm. Sebastian Osakwe, the awards would form part of the company continuing effort to recognise and celebrate partners who contribute to the company’s growth, with more partners expected to be honoured at subsequent editions of PACT.





